Literature DB >> 32732633

What we talk about when we talk about durable viral suppression.

Karen Diepstra1, Haidong Lu1, Kathleen A McManus2, Elizabeth T Rogawski McQuade2,3, Anne G Rhodes4, Daniel Westreich1.   

Abstract

: As policies built on 'Undetectable = Untransmittable' become more popular, use of durable viral suppression (DVS) as an outcome in analyses is increasing. We identified a case series of recent HIV-related publications that study the DVS outcome. The majority did not distinguish between a definition of DVS and the operationalization of that definition. Clearer discussion of DVS, including a formal definition, is needed to ensure better comparability across studies and ultimately better public health outcomes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32732633      PMCID: PMC7845768          DOI: 10.1097/QAD.0000000000002612

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  20 in total

1.  Racial and Ethnic Differences in Viral Suppression Among HIV-Positive Women in Care.

Authors:  Ndidi Nwangwu-Ike; Emma L Frazier; Nicole Crepaz; Yunfeng Tie; Madeline Y Sutton
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

2.  Place-based predictors of HIV viral suppression and durable suppression among heterosexuals in New York city.

Authors:  Kevin A Jefferson; Laura S Kersanske; Mary E Wolfe; Sarah L Braunstein; Regine Haardörfer; Don C Des Jarlais; Aimee N C Campbell; Hannah Lf Cooper
Journal:  AIDS Care       Date:  2018-11-26

3.  Multilevel Factors Associated with a Lack of Viral Suppression Among Persons Living with HIV in a Federally Funded Housing Program.

Authors:  Christopher M Beattie; Ellen W Wiewel; Yaoyu Zhong; Paul A Brown; Sarah L Braunstein; X Pamela Farquhar; John Rojas
Journal:  AIDS Behav       Date:  2019-03

4.  What's All This Fuss I Hear About Viral "Blips"?

Authors:  Michael S Saag
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

5.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Authors:  Benigno Rodríguez; Ajay K Sethi; Vinay K Cheruvu; Wilma Mackay; Ronald J Bosch; Mari Kitahata; Stephen L Boswell; W Christopher Mathews; David R Bangsberg; Jeffrey Martin; Christopher C Whalen; Scott Sieg; Suhrida Yadavalli; Steven G Deeks; Michael M Lederman
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

6.  Brief Report: Higher Levels of Angiopoietin-1 Are Associated With Early and Sustained Viral Suppression in Children Living With Vertically Acquired HIV.

Authors:  Vishrut Gulhati; Jeremy Soo; Doris G Ransy; Jason Brophy; Fatima Kakkar; Ari Bitnun; Lindy Samson; Stanley Read; Hugo Soudeyns; Michael T Hawkes
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-15       Impact factor: 3.731

7.  Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.

Authors:  Jennifer LeMessurier; Gregory Traversy; Olivia Varsaneux; Makenzie Weekes; Marc T Avey; Oscar Niragira; Robert Gervais; Gordon Guyatt; Rachel Rodin
Journal:  CMAJ       Date:  2018-11-19       Impact factor: 8.262

8.  Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.

Authors:  Margaret Nyaku; Linda Beer; Fengjue Shu
Journal:  AIDS Care       Date:  2018-10-11

9.  Changes in viral suppression status among US HIV-infected patients receiving care.

Authors:  Nicole Crepaz; Tian Tang; Gary Marks; H Irene Hall
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

10.  HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care.

Authors:  Eva A Enns; Cavan S Reilly; Keith J Horvath; Karen Baker-James; Keith Henry
Journal:  AIDS Behav       Date:  2019-09
View more
  2 in total

1.  Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy.

Authors:  Haidong Lu; Stephen R Cole; Daniel Westreich; Michael G Hudgens; Adaora A Adimora; Keri N Althoff; Michael J Silverberg; Kate Buchacz; Jun Li; Jessie K Edwards; Peter F Rebeiro; Viviane D Lima; Vincent C Marconi; Timothy R Sterling; Michael A Horberg; M John Gill; Mari M Kitahata; Joseph J Eron; Richard D Moore
Journal:  AIDS       Date:  2022-02-01       Impact factor: 4.632

2.  Medicaid Expansion's Impact on Human Immunodeficiency Virus Outcomes in a Nonurban Southeastern Ryan White HIV/AIDS Program Clinic.

Authors:  Kathleen A McManus; Karishma Srikanth; Samuel D Powers; Rebecca Dillingham; Elizabeth T Rogawski McQuade
Journal:  Open Forum Infect Dis       Date:  2020-12-28       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.